Type-II Diabetes and Pancreatic Cancer: a Meta-analysis of 36 Studies

Overview

Journal Br J Cancer

Specialty Oncology

Date 2005 May 12

PMID 15886696

Citations 417

Authors

R Huxley

A Ansary-Moghaddam

A Berrington de Gonzalez

F Barzi

M Woodward

Affiliations

Soon will be listed here.

Abstract

Pancreatic cancer is the eighth major form of cancer-related death worldwide, causing 227 000 deaths annually. Type-II diabetes is widely considered to be associated with pancreatic cancer, but whether this represents a causal or consequential association is unclear. We conducted a meta-analysis to examine this association. A computer-based literature search from 1966 to 2005 yielded 17 case-control and 19 cohort or nested case-control studies with information on 9220 individuals with pancreatic cancer. The age and sex-adjusted odds ratio (OR) for pancreatic cancer associated with type-II diabetes was obtained from each study. The combined summary odds ratio was 1.82 (95% confidence interval (95% CI) 1.66-1.89), with evidence of heterogeneity across the studies (P=0.002 for case-control and P=0.05 for cohort studies) that was explained, in part, by higher risks being reported by smaller studies and studies that reported before 2000. Individuals in whom diabetes had only recently been diagnosed (< 4 years) had a 50% greater risk of the malignancy compared with individuals who had diabetes for > or =5 years (OR 2.1 vs 1.5; P=0.005). These results support a modest causal association between type-II diabetes and pancreatic cancer.

Citing Articles

Explainable Prediction of Long-Term Glycated Hemoglobin Response Change in Finnish Patients with Type 2 Diabetes Following Drug Initiation Using Evidence-Based Machine Learning Approaches.

Chandra G, Lavikainen P, Siirtola P, Tamminen S, Ihalapathirana A, Laatikainen T Clin Epidemiol. 2025; 17:225-240.

PMID: 40078337 PMC: 11899941. DOI: 10.2147/CLEP.S505966.

Discovering Signature Disease Trajectories in Pancreatic Cancer and Soft-tissue Sarcoma from Longitudinal Patient Records.

Wang L, Li R, Wen A, Lu Q, Wang J, Ruan X medRxiv. 2025; .

PMID: 40034771 PMC: 11875324. DOI: 10.1101/2025.02.19.25322573.

Palliative biliodigestive bypass for unresectable pancreatic malignancy at Kilimanjaro Christian medical centre: a retrospective cross-sectional study.

Mutombo F, Tsandiraki J, Mchihiyo T, Wampembe E, Kennedy M, Lodhia J BMC Gastroenterol. 2025; 25(1):103.

PMID: 39984838 PMC: 11846214. DOI: 10.1186/s12876-025-03683-8.

Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status.

Hu C, Chen Y, Yin X, Xu R, Yin C, Wang C Signal Transduct Target Ther. 2025; 10(1):39.

PMID: 39948335 PMC: 11825823. DOI: 10.1038/s41392-024-02098-3.

Investigating the Inhibitory Effects of Paliperidone on RAGEs: Docking, DFT, MD Simulations, MMPBSA, MTT, Apoptosis, and Immunoblotting Studies.

Singh A, Ahmad S, Roy A, Raza K, Gautam H Int J Mol Sci. 2025; 26(3).

PMID: 39940823 PMC: 11817405. DOI: 10.3390/ijms26031060.

References

Lee C, Chang F, Lee S . Risk factors for pancreatic cancer in orientals. J Gastroenterol Hepatol. 1996; 11(5):491-5. DOI: 10.1111/j.1440-1746.1996.tb00296.x. View

Anderson K, Johnson T, Lazovich D, Folsom A . Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer. J Natl Cancer Inst. 2002; 94(15):1168-71. DOI: 10.1093/jnci/94.15.1168. View

Zendehdel K, Nyren O, Ostenson C, Adami H, Ekbom A, Ye W . Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst. 2003; 95(23):1797-800. DOI: 10.1093/jnci/djg105. View

Martinenghi S, DellAntonio G, Secchi A, Di Carlo V, Pozza G . Cancer arising after pancreas and/or kidney transplantation in a series of 99 diabetic patients. Diabetes Care. 1997; 20(3):272-5. DOI: 10.2337/diacare.20.3.272. View

Gapstur S, Gann P, Lowe W, Liu K, Colangelo L, Dyer A . Abnormal glucose metabolism and pancreatic cancer mortality. JAMA. 2000; 283(19):2552-8. DOI: 10.1001/jama.283.19.2552. View

Hiatt R, Klatsky A, Armstrong M . Pancreatic cancer, blood glucose and beverage consumption. Int J Cancer. 1988; 41(6):794-7. DOI: 10.1002/ijc.2910410603. View

Ragozzino M, Melton 3rd L, Chu C, PALUMBO P . Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis. 1982; 35(1):13-9. DOI: 10.1016/0021-9681(82)90025-x. View

Inoue M, Tajima K, Takezaki T, Hamajima N, Hirose K, Ito H . Epidemiology of pancreatic cancer in Japan: a nested case-control study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). Int J Epidemiol. 2003; 32(2):257-62. DOI: 10.1093/ije/dyg062. View

Davey Smith G, Bracha Y, Svendsen K, Neaton J, Haffner S, Kuller L . Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial. Ann Intern Med. 2005; 142(5):313-22. DOI: 10.7326/0003-4819-142-5-200503010-00006. View

10.

Batty G, Shipley M, Marmot M, Davey Smith G . Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study. Cancer Causes Control. 2004; 15(9):873-81. DOI: 10.1007/s10552-004-1050-z. View

11.

Mihara T, Oohashi H, Hirata Y . Mortality of Japanese diabetics in a seven-year follow-up study. Diabetes Res Clin Pract. 1986; 2(3):139-44. DOI: 10.1016/s0168-8227(86)80015-8. View

12.

Coughlin S, Calle E, Teras L, Petrelli J, Thun M . Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol. 2004; 159(12):1160-7. DOI: 10.1093/aje/kwh161. View

13.

Cull C, Neil H, Holman R . Changing aspirin use in patients with Type 2 diabetes in the UKPDS. Diabet Med. 2004; 21(12):1368-71. DOI: 10.1111/j.1464-5491.2004.01328.x. View

14.

Wang F, Herrington M, Larsson J, Permert J . The relationship between diabetes and pancreatic cancer. Mol Cancer. 2003; 2:4. PMC: 149418. DOI: 10.1186/1476-4598-2-4. View

15.

Friedman G, Van Den Eeden S . Risk factors for pancreatic cancer: an exploratory study. Int J Epidemiol. 1993; 22(1):30-7. DOI: 10.1093/ije/22.1.30. View

16.

Silverman D, Schiffman M, Everhart J, Goldstein A, Lillemoe K, Swanson G . Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer. 1999; 80(11):1830-7. PMC: 2363127. DOI: 10.1038/sj.bjc.6690607. View

17.

Wynder E, Mabuchi K, Maruchi N, Fortner J . Epidemiology of cancer of the pancreas. J Natl Cancer Inst. 1973; 50(3):645-67. DOI: 10.1093/jnci/50.3.645. View

18.

Mills P, Beeson W, Abbey D, Fraser G, Phillips R . Dietary habits and past medical history as related to fatal pancreas cancer risk among Adventists. Cancer. 1988; 61(12):2578-85. DOI: 10.1002/1097-0142(19880615)61:12<2578::aid-cncr2820611232>3.0.co;2-0. View

19.

Whittemore A, Paffenbarger Jr R, Anderson K, Halpern J . Early precursors of pancreatic cancer in college men. J Chronic Dis. 1983; 36(3):251-6. DOI: 10.1016/0021-9681(83)90059-0. View

20.

Adami H, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D . Cancer risk in patients with diabetes mellitus. Cancer Causes Control. 1991; 2(5):307-14. DOI: 10.1007/BF00051670. View